Cargando…

The current state of biomarker research for Friedreich’s ataxia: a report from the 2018 FARA biomarker meeting

The 2018 FARA Biomarker Meeting highlighted the current state of development of biomarkers for Friedreich’s ataxia. A mass spectroscopy assay to sensitively measure mature frataxin (reduction of which is the root cause of disease) is being developed. Biomarkers to monitor neurological disease progre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blair, Ian A, Farmer, Jennifer, Hersch, Steven, Larkindale, Jane, Lynch, David R, Napierala, Jill, Napierala, Marek, Payne, R Mark, Subramony, Sub H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609901/ https://www.ncbi.nlm.nih.gov/pubmed/31285843 http://dx.doi.org/10.2144/fsoa-2019-0026

Ejemplares similares

Understanding the genetic and molecular pathogenesis of Friedreich’s ataxia through animal and cellular models
por: Martelli, Alain, et al.
Publicado: (2012)

Somatic instability of the expanded GAA repeats in Friedreich’s ataxia
por: Long, Ashlee, et al.
Publicado: (2017)

Friedreich's ataxia – a case of aberrant transcription termination?
por: Butler, Jill Sergesketter, et al.
Publicado: (2015)

Selected missense mutations impair frataxin processing in Friedreich ataxia
por: Clark, Elisia, et al.
Publicado: (2017)

Reverse Phase Protein Array Reveals Correlation of Retinoic Acid Metabolism With Cardiomyopathy in Friedreich's Ataxia
por: Napierala, Jill S., et al.
Publicado: (2021)

Potential biomarker identification for Friedreich’s ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion
por: McMackin, Marissa Z., et al.
Publicado: (2019)

Skin fibroblast metabolomic profiling reveals that lipid dysfunction predicts the severity of Friedreich’s ataxia
por: Wang, Dezhen, et al.
Publicado: (2022)

Comprehensive analysis of gene expression patterns in Friedreich's ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers
por: Napierala, Jill Sergesketter, et al.
Publicado: (2017)

Deep sequencing of mitochondrial genomes reveals increased mutation load in Friedreich's ataxia
por: Bhalla, Angela D., et al.
Publicado: (2016)

A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich’s Ataxia Patients
por: Misiorek, Julia O., et al.
Publicado: (2020)

Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich’s ataxia
por: Kim, Eunah, et al.
Publicado: (2011)

Selected Histone Deacetylase Inhibitors Reverse the Frataxin Transcriptional Defect in a Novel Friedreich’s Ataxia Induced Pluripotent Stem Cell-Derived Neuronal Reporter System
por: Schreiber, Anna M., et al.
Publicado: (2022)

Premature transcription termination at the expanded GAA repeats and aberrant alternative polyadenylation contributes to the Frataxin transcriptional deficit in Friedreich’s ataxia
por: Li, Yanjie, et al.
Publicado: (2022)

Impact of diabetes in the Friedreich ataxia clinical outcome measures study
por: McCormick, Ashley, et al.
Publicado: (2017)

Clinical management guidelines for Friedreich ataxia: best practice in rare diseases
por: Corben, Louise A., et al.
Publicado: (2022)

Predictors of loss of ambulation in Friedreich's ataxia
por: Rummey, Christian, et al.
Publicado: (2020)

Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia
por: Fil, Daniel, et al.
Publicado: (2020)

Frataxin levels in peripheral tissue in Friedreich ataxia
por: Lazaropoulos, Michael, et al.
Publicado: (2015)

Psychometric properties of the Friedreich Ataxia Rating Scale
por: Rummey, Christian, et al.
Publicado: (2019)

Measuring peripheral nerve involvement in Friedreich’s ataxia
por: Creigh, Peter D., et al.
Publicado: (2019)

Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia
por: Lynch, David R., et al.
Publicado: (2018)

Progression of Friedreich ataxia: quantitative characterization over 5 years
por: Patel, Maya, et al.
Publicado: (2016)

Longitudinal analysis of contrast acuity in Friedreich ataxia
por: Hamedani, Ali G., et al.
Publicado: (2018)

Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions
por: Lynch, David R., et al.
Publicado: (2021)

Long intronic GAA•TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia
por: Soragni, E., et al.
Publicado: (2008)

Test–retest reliability of the Friedreich’s ataxia rating scale
por: Rummey, Christian, et al.
Publicado: (2020)

Randomized, double‐blind, placebo‐controlled study of interferon‐γ 1b in Friedreich Ataxia
por: Lynch, David R., et al.
Publicado: (2019)

Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort
por: Rummey, Christian, et al.
Publicado: (2021)

Liquid Chromatography–Mass Spectrometry Analysis of Frataxin Proteoforms in Whole Blood as Biomarkers of the Genetic Disease Friedreich’s Ataxia
por: Rojsajjakul, Teerapat, et al.
Publicado: (2023)

The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
por: Frempong, Bernice, et al.
Publicado: (2021)

Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)
por: Lynch, David R., et al.
Publicado: (2020)

Gauging Gait Disorders with a Method Inspired by Motor Control Theories: A Pilot Study in Friedreich’s Ataxia
por: Gouelle, Arnaud, et al.
Publicado: (2021)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

Friedreich Ataxia: Multidisciplinary Clinical Care
por: Lynch, David R, et al.
Publicado: (2021)

Natural History of Friedreich Ataxia: Heterogeneity of Neurologic Progression and Consequences for Clinical Trial Design
por: Rummey, Christian, et al.
Publicado: (2022)

Cardiovascular Research in Friedreich Ataxia: Unmet Needs and Opportunities
por: Payne, R. Mark
Publicado: (2022)

Body Mass Index and Height in the Friedreich Ataxia Clinical Outcome Measures Study
por: Patel, Maya, et al.
Publicado: (2021)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Central Nervous System Therapeutic Targets in Friedreich Ataxia
por: Harding, Ian H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rjdps5i0n3jjtasb83b6s0mfsh